https://www.selleckchem.com/pr....oducts/luzindole.htm
Pancreatic cancer is one of the deadliest cancers, with a 5-year survival rate of less then 10%. The current approach to confirming a tissue diagnosis, endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA), requires a time-consuming, qualitative cytology analysis and may be limited because of sampling error. We designed and engineered a miniaturized optoelectronic sensor to assist in situ, real-time, and objective evaluation of human pancreatic tissues during EUS-FNA. A proof-of-concept prototype sensor, compatible with a 19-g
Like
Comment
Share
